Publisher
Springer Science and Business Media LLC
Reference35 articles.
1. Kelleci K, Allahverdiyev A, Bağirova M, Ihlamur M, Abamor EŞ (2023) Particulate and non-particle adjuvants in Leishmaniasis vaccine designs: a review. J Vector Borne Dis 60(2):125–141
2. Allahverdiyev A, Bağirova M, Oztel ON, Elçıçek S, Ateş SC, Karaca TD (2010) Approaches and problems in vaccine development against leishmaniasis. Turkiye Parazitolojii Dergisi 34(2):122–130
3. Kelleci K (2022) Determination of Immunostimulatory Efficacy of Benzimidazole Derivatives Against Leishmania infantum. Sys Rev Pharm 2022; 13(12): 826–830
4. Kelleci K, Gölebatmaz E (2023) In Vitro determination of Antileshmanial activities of Benzimidazolium derivatives on L. major promastigotes and amastigotes. Acta Parasitol 68(1):51–55
5. Severino P, Santana W, Lisboa ES, Santos VLD, Lima ETDS, Cardoso JC, Jain S (2022) Cutaneous/Mucocutaneous Leishmaniasis Treatment for Wound Healing: classical versus New Treatment approaches. Microbiol Res 13(4):836–852